Cathay Biotech Inc (688065) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.003x

Based on the latest financial reports, Cathay Biotech Inc (688065) has a cash flow conversion efficiency ratio of -0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-66.22 Million ≈ $-9.69 Million USD) by net assets (CN¥21.22 Billion ≈ $3.10 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 688065 company net worth for the company's overall valuation and market capitalisation.

Cathay Biotech Inc - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Cathay Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Cathay Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cathay Biotech Inc ranked by their cash flow conversion efficiency. Explore Cathay Biotech Inc earnings quality ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
State Grid Yingda Co Ltd SHG:600517	-0.022x
China Hainan Rubber Industry Group Co Ltd SHG:601118	-0.035x
Fujian Star Net Communic Ltd SHE:002396	0.060x
Co-Tech Development TWO:8358	0.000x
JCDECAUX SE ADR 1/2/O.N. F:DCS0	N/A
Legence Corp. Class A Common stock NASDAQ:LGN	0.076x
Just Eat Takeaway AS:TKWY	0.039x
Forehope Electronic (Ningbo) Co. Ltd. A SHG:688362	N/A

Annual Cash Flow Conversion Efficiency for Cathay Biotech Inc (2016–2025)

The table below shows the annual cash flow conversion efficiency of Cathay Biotech Inc from 2016 to 2025. View current stock price of Cathay Biotech Inc for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥45.10 Billion ≈ $6.60 Billion	CN¥404.12 Million ≈ $59.14 Million	0.009x	-83.52%
2024-12-31	CN¥15.10 Billion ≈ $2.21 Billion	CN¥820.93 Million ≈ $120.13 Million	0.054x	+41.03%
2023-12-31	CN¥14.77 Billion ≈ $2.16 Billion	CN¥569.45 Million ≈ $83.33 Million	0.039x	-27.87%
2022-12-31	CN¥15.04 Billion ≈ $2.20 Billion	CN¥803.67 Million ≈ $117.60 Million	0.053x	+32.10%
2021-12-31	CN¥14.69 Billion ≈ $2.15 Billion	CN¥594.18 Million ≈ $86.95 Million	0.040x	-9.78%
2020-12-31	CN¥11.48 Billion ≈ $1.68 Billion	CN¥514.96 Million ≈ $75.36 Million	0.045x	-42.12%
2019-12-31	CN¥4.64 Billion ≈ $679.25 Million	CN¥359.62 Million ≈ $52.62 Million	0.077x	+2477.46%
2018-12-31	CN¥3.16 Billion ≈ $461.93 Million	CN¥-10.29 Million ≈ $-1.51 Million	-0.003x	-113.39%
2017-12-31	CN¥2.20 Billion ≈ $321.46 Million	CN¥53.45 Million ≈ $7.82 Million	0.024x	+123.05%
2016-12-31	CN¥1.22 Billion ≈ $178.35 Million	CN¥-128.67 Million ≈ $-18.83 Million	-0.106x	--

About Cathay Biotech Inc

SHG:688065 China Chemicals

Market Cap

$4.05 Billion

CN¥27.65 Billion CNY

Market Cap Rank

#4081 Global

#607 in China

Share Price

CN¥38.34

Change (1 day)

-2.49%

52-Week Range

CN¥37.00 - CN¥62.24

All Time High

CN¥134.07